Ping Wee

Cancer Biologist. Let’s go snowboarding. Listen to John Frusciante for a healthy soul.

[entospharma @entospharma]

We’re excited to announce we’ve entered into an exclusive research and collaboration agreement with @LillyPad. Under the agreement, we’ll work with Lilly to develop therapies targeting the central and peripheral nervous systems. Details here: https://t.co/rB4R6ef8Gr
#plv

[entospharma @entospharma]

Very exciting few days!

[Jason Kenney 🇨🇦🇺🇦🇮🇱 @jkenney]

Two made-in-Alberta prototype vaccines for #COVID19 will soon be ready for clinical human trials this summer.

Very impressive work from Edmonton-based ⁦@entospharma⁩ and Dr. John Lewis’ team. https://t.co/OawGh15BRo

[CityNews Edmonton @CityNewsYEG]

In the rush for a vaccine against #COVID19, a spinoff from the @UAlberta is looking to DNA and genetics. As @CarlyDRobinson reports, @EntosPharma hopes to one day use the same technology for a vaccine against cancer. #YEG #COVID19AB

[Health Cities @HealthCities]

ICYMI: Edmonton company @entospharma is developing a fusogenix DNA vaccine against #COVID19: https://t.co/W0KPbZedsn

How does the fusogenix DNA vaccine work? Watch this and find out.

#HealthTech #Innovation #Vaccine #Alberta #Canada

[entospharma @entospharma]

More info @ https://t.co/Qrxzv5hPne too!

[entospharma @entospharma]

We're in San Francisco for #JPM20! Entos develops next-gen nucleic acid-therapies with our proprietary delivery system: Fusogenix. DM CEO John Lewis @APCaRI_CA and CSO Arun Raturi @arunraturi to learn more! https://t.co/Qrxzv5hPne #biopharma #HealthTech #JPM2020

[entospharma @entospharma]

Entos in the news! Please read current @folioUAlberta
report on our $109M partnership to create new inflammatory disease therapies with a biopharma company. #HealthTech #ABbiz #biopharma
https://t.co/4EXKWYW44V
https://t.co/ixcte8xXXB

[JLABS @JLABS]

Friday good news for #JLABSSD companies! Resident, Entos Pharmaceuticals and alumni, Prometheus Biosciences have each announced a new partnership! Read the news: https://t.co/SkTXhbA5fe & https://t.co/MQyzX75p1R

[Ping Wee @pinger_21]

Exciting news from our company!

[entospharma @entospharma]

@entospharma is excited to announce a new partnership with a clinical-stage biopharma company to develop new therapeutics with our Fusogenix tech to target autoimmune and inflammatory diseases. https://t.co/iLCbcuUGNE #pressreleases #immunotherapy #nextgeneration

[Ping Wee @pinger_21]

Hey, it's my review on EGFR signaling! https://t.co/Mx8FFai1s9

[Cancers MDPI @Cancers_MDPI]

A comprehensive review on #EGFR: Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways https://t.co/omOHNelD45

[Ping Wee @pinger_21]

The big announcement: Edmonton's #babc16 raised over $175,000 towards a future without breast cancer. Wow! @CBCF

[Ping Wee @pinger_21]

Thanks Ricky's All Day Grill for your continued support of #babc16 with your delicious pancake breakfast!

[Ping Wee @pinger_21]

Thank you @DoubleTreeYEG for your support as a diamond sponsor at #babc16. Stop by for some delicious FREE cookies!

[Ping Wee @pinger_21]

Free public lecture from the pioneer of Herceptin, the widely used breast cancer drug! Tuesday May 24th from 7-8pm.

https://t.co/9gfynQFZuC

[Ping Wee @pinger_21]

Thanks for another great year at #BABC15yeg! https://t.co/dHan6WzDI4

[Ping Wee @pinger_21]

$208,000! Crazy! https://t.co/Pe7Gxmf1hH

[Ping Wee @pinger_21]

She's a goner! #BABACyeg15 @CBCF_PNWT

[Ping Wee @pinger_21]

Saving Cups A-DD of the Rec Division #BABC15yeg @CBCF_PNWT

[Ping Wee @pinger_21]

Prab enjoying a free pancake breakfast courtesy of Ricky's All Day Grill #BABC15yeg . Verdict: Delicious! @CBCF_PNWT